Medical Giant Convatec Selects Manchester for Flagship Research Center

02-10-2025


Global medical technology company Convatec has announced plans to establish a new flagship research and development hub in Manchester as part of a £500 million investment in the United Kingdom. The FTSE100-listed firm, which specializes in products for chronic wounds, diabetes, urinary incontinence, and stomas, will relocate its R&D operations from Deeside to Bruntwood SciTech's CityLabs 4.0 facility, scheduled to open in 2027. This strategic move represents a significant commitment to the UK's life sciences sector at a time when several other pharmaceutical companies have been shifting investments overseas.

The new Manchester facility will become one of the largest centers in Convatec's global network, spanning 125,000 square feet across seven storeys in the £42 million CityLabs 4.0 building. Located on Hathersage Road facing the Manchester Royal Infirmary, St Mary's and Royal Manchester Children's Hospital, the state-of-the-art facility will focus on research in four key therapeutic areas: advanced wound care, ostomy care, continence care, and infusion care. The company cited Manchester's "vibrant life sciences ecosystem, which includes leading universities, hospitals, and research institutions" as the primary reason for selecting the location.

Approximately 200 staff will be employed at the new Manchester hub, with most positions transferring from Convatec's existing R&D operation in Deeside, North Wales, which has served as a major research center since 1996. The company emphasized that no redundancies are planned as a consequence of the relocation and that the Deeside manufacturing site will remain unaffected, continuing to employ around 400 workers. The new Manchester facility is approximately 50% larger than the current Deeside operation and has capacity for up to 250 employees, allowing for future expansion.

Convatec's investment comes as part of a broader $1 billion worldwide R&D commitment, with the UK portion representing nearly half of this global initiative. The company, which generated $2.3 billion in revenue last year, typically allocates approximately 5% of its annual revenue to research and development. The relocation to Manchester positions Convatec to leverage the city's concentration of medical research institutions, including neighboring organizations such as the University of Manchester NHS Foundation Trust, biotech company QIAGEN, and MAC Clinical Research, strengthening its pipeline of new products addressing unmet needs in chronic care.

Other news

Three Teenagers Arrested Following Youth Brawl at Buttercrane Centre

{'$date': '2025-10-20T11:47:28.108Z'}


Police in Newry are investigating a violent altercation that occurred outside the Buttercrane Shopping Centre on Francis Street on Saturday evening. The incident, which involved a group of young males, took place at approximately 5:40 pm on October 18, prompting emergency services to respond to the scene.

Three teenagers were arrested in connection with the disturbance, including two 17-year-olds and one 16-year-old. Law enforcement officials confirmed the arrests were made on suspicion of multiple offenses, including attempted grievous bodily harm with intent, assault occasioning actual bodily harm, and possession of an offensive weapon.

Two of the detained males, aged 16 and 17, have been released on bail pending further police inquiries, while the other 17-year-old was released unconditionally. The Police Service of Northern Ireland continues to investigate the circumstances surrounding the altercation that began at the shopping center and continued onto the adjacent street.

Authorities are particularly concerned about a male youth believed to have been assaulted during the incident who left the scene before officers arrived. Inspector Ritchie stated that police have concerns for the individual's wellbeing and are urging him to come forward. Witnesses or anyone with dash-cam or CCTV footage are asked to contact Ardmore police station quoting reference number 1120 of 18/10/25.